DE602007008952D1 - Imidazolidinonylaminopyrimidinverbindungen zur behandlung von krebs - Google Patents

Imidazolidinonylaminopyrimidinverbindungen zur behandlung von krebs

Info

Publication number
DE602007008952D1
DE602007008952D1 DE602007008952T DE602007008952T DE602007008952D1 DE 602007008952 D1 DE602007008952 D1 DE 602007008952D1 DE 602007008952 T DE602007008952 T DE 602007008952T DE 602007008952 T DE602007008952 T DE 602007008952T DE 602007008952 D1 DE602007008952 D1 DE 602007008952D1
Authority
DE
Germany
Prior art keywords
hydrogen
halo
cancer
treatment
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602007008952T
Other languages
German (de)
English (en)
Inventor
Hong-Yu Li
Harold Burns Brooks
Joyce Z Crich
James Robert Henry
Melissa Kate Slater
Yan Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of DE602007008952D1 publication Critical patent/DE602007008952D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4436Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE602007008952T 2006-12-21 2007-12-11 Imidazolidinonylaminopyrimidinverbindungen zur behandlung von krebs Active DE602007008952D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87130206P 2006-12-21 2006-12-21
PCT/US2007/087044 WO2008076704A1 (en) 2006-12-21 2007-12-11 Imidazolidinonyl aminopyrimidine compounds for the treatment' of cancer

Publications (1)

Publication Number Publication Date
DE602007008952D1 true DE602007008952D1 (de) 2010-10-14

Family

ID=39186811

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602007008952T Active DE602007008952D1 (de) 2006-12-21 2007-12-11 Imidazolidinonylaminopyrimidinverbindungen zur behandlung von krebs

Country Status (14)

Country Link
US (1) US8101628B2 (enExample)
EP (1) EP2125793B1 (enExample)
JP (1) JP5166441B2 (enExample)
KR (1) KR101088291B1 (enExample)
CN (1) CN101563342B (enExample)
AT (1) ATE479680T1 (enExample)
AU (1) AU2007334039B2 (enExample)
BR (1) BRPI0721045A2 (enExample)
CA (1) CA2671738A1 (enExample)
DE (1) DE602007008952D1 (enExample)
EA (1) EA016177B1 (enExample)
ES (1) ES2349169T3 (enExample)
MX (1) MX2009006634A (enExample)
WO (1) WO2008076704A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA016178B1 (ru) 2006-12-21 2012-02-28 Эли Лилли Энд Компани Соединения имидазолидинониламинопиримидина
AR066473A1 (es) 2007-05-16 2009-08-19 Lilly Co Eli Compuesto de triazolil aminopirimidina, composicion farmaceutica que lo comprende y su uso para preparar un medicamento util para tratar cancer
CL2008001322A1 (es) 2007-05-16 2009-05-22 Lilly Co Eli Compuestos derivados de triazolil-aminopirimidina, sustituida con heterociclos; composicion farmaceutica; y uso en el tratamiento del cancer.
CN108853111B (zh) * 2018-08-07 2020-06-05 浙江大学 一种组合物在制备治疗吉非替尼肝脏毒性药物中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4929726A (en) 1988-02-09 1990-05-29 Georgia State University Foundation, Inc. Novel diazines and their method of preparation
US6939877B2 (en) * 2002-09-12 2005-09-06 Wyeth Antidepressant piperidine derivatives of heterocycle-fused benzodioxans
WO2004063192A1 (en) * 2003-01-10 2004-07-29 Pharmacopeia Drug Discovery, Inc. Imidazolyl pyrimidine derivatives useful as il-8 receptor modulators
GB0308466D0 (en) 2003-04-11 2003-05-21 Novartis Ag Organic compounds
US7329764B2 (en) * 2003-07-31 2008-02-12 Boehringer Ingelheim Pharmaceuticals, Inc. Substitute benzothiophene compounds
AU2005316312B2 (en) * 2004-12-17 2009-10-22 Amgen, Inc. Aminopyrimidine compounds and methods of use
TW200800201A (en) 2005-11-18 2008-01-01 Lilly Co Eli Pyrimidinyl benzothiophene compounds
US8008481B2 (en) * 2006-03-31 2011-08-30 Ericsson Anna M Indazole compounds
EA016178B1 (ru) 2006-12-21 2012-02-28 Эли Лилли Энд Компани Соединения имидазолидинониламинопиримидина
AR066473A1 (es) 2007-05-16 2009-08-19 Lilly Co Eli Compuesto de triazolil aminopirimidina, composicion farmaceutica que lo comprende y su uso para preparar un medicamento util para tratar cancer
CL2008001322A1 (es) 2007-05-16 2009-05-22 Lilly Co Eli Compuestos derivados de triazolil-aminopirimidina, sustituida con heterociclos; composicion farmaceutica; y uso en el tratamiento del cancer.

Also Published As

Publication number Publication date
EP2125793A1 (en) 2009-12-02
KR20090086114A (ko) 2009-08-10
CN101563342B (zh) 2012-09-05
AU2007334039A1 (en) 2008-06-26
AU2007334039B2 (en) 2012-02-16
CA2671738A1 (en) 2008-06-26
CN101563342A (zh) 2009-10-21
EP2125793B1 (en) 2010-09-01
JP5166441B2 (ja) 2013-03-21
ES2349169T3 (es) 2010-12-28
JP2010513552A (ja) 2010-04-30
US8101628B2 (en) 2012-01-24
MX2009006634A (es) 2009-06-30
BRPI0721045A2 (pt) 2014-07-29
ATE479680T1 (de) 2010-09-15
EA016177B1 (ru) 2012-02-28
WO2008076704A1 (en) 2008-06-26
KR101088291B1 (ko) 2011-11-30
US20100076001A1 (en) 2010-03-25
EA200970615A1 (ru) 2009-10-30

Similar Documents

Publication Publication Date Title
BRPI0510177B8 (pt) composto, composição farmacêutica e uso do mesmo
JO3007B1 (ar) مركبات و تركيبات كمثبطات كيناز بروتين
CY1110900T1 (el) Χημικες ενωσεις
CY1108275T1 (el) Χημικες ενωσεις
EA201000100A1 (ru) Гетероциклические соединения, полезные в качестве ингибиторов mk2
TW200716606A (en) Chemical compounds
TW200800963A (en) Chemical compounds
EA200900023A1 (ru) Применение замещенных 2-аминотетралинов для изготовления лекарственного средства для предупреждения, облегчения и/или лечения разных видов боли
EA200870193A1 (ru) Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение
UA102251C2 (ru) Производные аминодигидротиазина как ингибиторы васе для лечения болезни альцгеймера
MY149512A (en) Pyrazolylaminopyridine derivatives useful as kinase inhibitors
DE602007001463D1 (de) Pyrimidin-, chinazolin-, pteridin- und triazinderivate
TW200612936A (en) Indole derivatives
BRPI0408353A (pt) composto, composição farmacêutica, métodos para o tratamento de neoplasias suscetìveis e para o tratamento de infecções virais, e, uso de um composto
DE602006006712D1 (de) Thiazolylpiperidin-derivate nützlich als h3 rezeptor modulatoren
EA201170344A1 (ru) Азаиндольные ингибиторы iap
DE602004008959D1 (de) Benzoäbüä1,4üdioxepinderivate
MX2010007543A (es) Inhibidores de iap.
DE602007011434D1 (de) 1h-indol-5-ylpiperazin-1-ylmethanonderivate
TW200716547A (en) Piperidin-4-yl-amide derivatives
MY158069A (en) Tricyclic compound and pharmaceutical use thereof
DK1809288T3 (da) Anvendelse af 1,4-bis-(3-aminoalkyl)piperazinderivater ved behandling af neurodegenerative sygdomme
DE602007008952D1 (de) Imidazolidinonylaminopyrimidinverbindungen zur behandlung von krebs
DE602006010738D1 (de) Pyrroloä2,3-cüpyridinderivate
TW200639155A (en) Thiazolidinones, their production and use as pharmaceutical agents

Legal Events

Date Code Title Description
8328 Change in the person/name/address of the agent

Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN